U.S. court upholds Amgen patents on arthritis drug Enbrel
Aug 9 (Reuters) - A U.S. judge on Friday said patents relating to the Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel were valid, denying a...
Aug 9 (Reuters) - A U.S. judge on Friday said patents relating to the Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel were valid, denying a...